NeuroEPO ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	1

6. Parkinson disease

---

Clinical trials : 2,298 /  Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04110678 (ClinicalTrials.gov)	November 1, 2015	18/9/2019	Tolerance to NeuroEPO in Parkinson Disease	Nasal Administration of the NeuroEPO in Parkinson Disease: Short-term Tolerance Physician Lead Trial	Parkinson Disease	Drug: NeuroEPO	International Center for Neurological Restoration, Cuba	Center of Molecular Immunology, Cuba;University of Electronic Science and Technology of China	Completed	40 Years	70 Years	All	26	Phase 1/Phase 2	Cuba